Hutch News

Stories tagged 'metastasis'

Triple therapy for rare skin cancer shows promise in small, early-stage trial

Combo of T-cell therapy, newly FDA-approved drug and another immune booster kept cancer at bay for three of four patients with metastatic Merkel cell carcinoma

May 31, 2017 | By Rachel Tompa / Fred Hutch News Service

In a small, ongoing clinical trial testing a combination of three therapies, three of four patients with advanced Merkel cell carcinoma went into complete remission.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

May 25, 2017

A team of Fred Hutch researchers led by principal investigator Dr. Eric Holland has received $400,000 for a two-year pilot study to test several novel immunotherapy approaches for glioma, an aggressive brain cancer. The study was made possible by the generous support of the Bezos family, which since 2009 has donated and leveraged more than $40 million to Fred Hutch for immunotherapy research.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

March 31, 2017

Dr. Philip Greenberg elected to serve on AACR board of directors; five researchers receive awards to explore immunotherapy single-cell RNA sequencing.

View story >


Living with stage 4

In a culture focused on survivorship, those with metastatic breast cancer who will be in treatment for the rest of their lives can feel isolated and misunderstood

Oct. 13, 2016 | By Diane Mapes / Fred Hutch News Service

In a culture focused on survivorship, those with metastatic breast cancer who will be in treatment for the rest of their lives can feel isolated and misunderstood.

View story >


Inherited mutations tied to advanced prostate cancer

Genetic screening could help men with prostate cancer find better treatments — and alert family members to their own cancer risk

July 6, 2016 | By Sabrina Richards / Fred Hutch News Service

A new study shows men with metastatic prostate cancer are five times likelier to harbor inherited mutations in BRCA1/2 and other DNA-repair genes than the general population, irrespective of age or family history of prostate cancer.

View story >


The science of cancer spread

The how and why of metastasis — and what it might take to stop it

April 28, 2016 | By Rachel Tompa / Fred Hutch News Service

Metastasis, or cancer spread, is complex and still largely mysterious. What do researchers know -- and what do they still need to know to stop metastasis?

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.